M. Kowalewska, H. Kwiecien´ / Tetrahedron 64 (2008) 5085–5090
5089
n: 3500–3300,1740–1720,1700,1530 cmꢁ1. Anal. Calcd for C14H17NO7
(311.10): C, 54.02; H, 5.50; N, 4.50. Found: C, 53.91; H, 5.63; N, 4.57.
1540, 1170 cmꢁ1. Anal. Calcd for C12H13NO7 (283.07): C, 50.89; H,
4.63; N, 4.95. Found: C, 50.75; H, 4.69; N, 5.03.
4.4. Synthesis of 2-(2-formyl-6-methoxyphenoxy)butanoic
acid (1d)
4.6. Cyclization of 2-(2-formyl-6-methoxy-4-nitrophenoxy)-
pentanoic acid (1b)
Starting from 2-hydroxy-3-methoxybenzaldehyde (7.6 g,
0.05 mol), methyl 2-bromobutanoate (9.1 g, 0.05 mol), potassium
carbonate(6.9 g, 0.05 mol)andDMF(90 mL)thesameprocedurewas
followed as described for compound 1a. The ester was hydrolyzed by
heating with 5% KOH on a boiling water bath for 2.5 h, to give 1d as
pale beige crystals (8.9 g, 75%), mp 112–113 ꢀC (lit.1f 113–114.5 ꢀC).
GC/MS, MS m/z: 238 (Mþ, 21%), 220 (1%), 207 (2%),194 (14%),179
(2%), 165 (8%), 152 (100%), 137 (11%), 122 (18%), 106 (68%), 93 (8%),
77 (9%), 52 (6%). 1H NMR d 10.62 (s, 1H, COOH), 10.48 (s, 1H, CHO),
7.41 (t, J¼4.4, 1H, Ar), 7.14 (d, J¼3.9, 2H, Ar), 5.03 (t, J¼5.5, 1H, CH),
3.86 (s, 3H, OCH3), 2.10–2.01 (m, 2H, CH2), 1.11 (t, J¼7.4, 3H, CH3).
Starting from acid 1b (2.08 g, 0.007 mol), acetic anhydride
(35 mL) and sodium acetate (5.7 g, 0.07 mol) following a similar
procedure to that described for 1a yielded pure 2b as a beige solid
(0.68 g, 41%). Compounds 3b and 4b were identified in the crude
reaction mixture by GC/MS analysis.
4.6.1. 2-Propyl-7-methoxy-5-nitrobenzo[b]fuþran (2b)
Mp 72–74 ꢀC, GC/MS, MS m/z: 235 (M , 87%), 220 (1%), 206
(100%), 189 (17%), 174 (3%), 160 (49%), 145 (5%), 131 (3%), 117 (17%),
103 (3%), 89 (7%), 76 (3%), 63 (4%), 50 (1%). 1H NMR d 8.07 (s, 1H, Ar),
7.66 (s, 1H, Ar), 6.51 (s, 1H, Ar), 4.08 (s, 3H, OCH3), 2.79 (t, J¼7.4, 2H,
CH2), 1.83–1.78 (m, 2H, CH2), 1.02 (t, J¼7.3, 3H, CH3); 13C NMR
d 162.8, 146.9, 144.5, 144.5, 129.9, 109.8, 103.2, 101.2, 56.5, 30.3, 20.9,
4.5. Cyclization of 2-(2-formyl-6-methoxy-4-nitrophenoxy)-
butanoic acid (1a)
13.7. IR (KBr) n: 3110–2920, 1600, 1590, 1530, 1425, 1340, 1320 cmꢁ1
.
Anal. Calcd for C12H13NO4 (235.08): C, 61.27; H, 5.57; N, 5.95.
Found: C, 61.18; H, 5.63; N, 5.99.
To a mixture of acetic anhydride (35 mL) and sodium acetate
(5.7 g, 0.07 mol), acid 1a (1.98 g, 0.007 mol) was added. The mix-
ture was stirred and heated at reflux for 3.5 h. After it was poured
into ice-water the precipitate was filtered. The crude product was
dissolved in methylene chloride, treated with 5% sodium bi-
carbonate and water. The organic layer was dried, evaporated and
the residue crude analyzed by GC/MS. The brown solid was
recrystallized from methanol to yield pure 2a (0.66 g, 44%) as
a beige solid. After methanol was removed from the filtrate on
a rotary evaporator, the residue was recrystallized from chloro-
form/hexane 1:3 to first yield colourless crystals, identified as 3a
(0.21 g, 9%) and secondly a pale yellow semisolid 4a (0.12 g, 6%).
4.6.2. 2-Propyl-3,5-dihydro-9-methoxy-7-nitro-3-oxo-2H-
benzo[e][1,4]dioxepin-5-yl acetate (3b)
GC/MS, MS m/z: 339 (Mþ, 1%), 311 (2%), 297 (19%), 252 (2%), 239
(5%), 224 (1%), 197 (100%), 180 (5%), 167 (3%), 151 (10%), 136 (3%),
122 (2%), 101 (2%), 83 (2%), 69 (1%), 55 (4%).
4.6.3. 2-Propyl-5-hydroxy-9-methoxy-7-nitro-5H-
benzo[e][1,4]dioxepin-3-one (4b)
GC/MS, MS m/z: 297 (Mþ, 19%), 252 (2%), 239 (5%), 224 (1%), 197
(100%), 180 (5%), 167 (3%), 151 (10%), 136 (3%), 122 (2%), 101 (2%), 83
(2%), 69 (1%), 55 (4%).
4.5.1. 2-Ethyl-7-methoxy-5-nitrobenzo[b]furþan (2a)
Mp 98–100 ꢀC, GC/MS, MS m/z: 221 (M , 100%), 206 (36%), 191
(5%), 175 (45%), 160 (19%), 145 (4%), 131 (5%), 115 (14%), 91 (7%), 77
(6%), 63 (4%), 50 (2%). 1H NMR d 8.07 (d, J¼2.0,1H, Ar), 7.66 (d, J¼2.0,
1H, Ar), 6.51 (s, 1H, Ar), 4.08 (s, 3H, OCH3), 2.87–2.85 (m, 2H, CH2),
1.39–1.35 (m, 3H, CH3); 13C NMR d 164.3, 146.9, 144.5, 144.5, 129.9,
109.8, 102.4, 101.2, 56.5, 21.8, 11.7. IR (KBr) n: 3110, 2980, 2930, 1600,
1590, 1530, 1430, 1335, 1325 cmꢁ1. Anal. Calcd for C11H11NO4
(221.07): C, 59.73; H, 5.01; N, 6.33. Found: C, 59.61; H, 5.13; N, 6.37.
4.7. Cyclization of 2-(2-formyl-6-methoxy-4-nitrophenoxy)-
hexanoic acid (1c)
Starting from acid 1c (2.18 g, 0.007 mol), acetic anhydride
(35 mL) and sodium acetate (5.7 g, 0.07 mol) following a similar
procedure to that described for 1a yielded pure 2c as a beige solid
(0.83 g, 49%). Compounds 3c and 4c were identified in the crude
reaction mixture by GC/MS analysis.
4.5.2. 2-Ethyl-3,5-dihydro-9-methoxy-7-nitro-3-oxo-2H-
benzo[e][1,4]dioxepin-5-yl acetate (3a)
4.7.1. 2-Butyl-7-methoxy-5-nitrobenzo[b]furan (2c)
Mp 45–47 ꢀC, GC/MS, 249 (Mþ, 78%), 234 (3%), 220 (2%), 206
(100%), 190 (9%), 174 (4%), 160 (50%), 145 (4%), 131 (3%), 117 (12%),
103 (4%), 89 (7%), 76 (3%), 63 (3%), 50 (1%). 1H NMR d 7.99 (s, 1H, Ar),
7.59 (s, 1H, Ar), 6.43 (s, 1H, Ar), 4.00 (s, 3H, OCH3), 2.75 (d, J¼6.6, 2H,
CH2), 1.68 (t, J¼6.5, 2H, CH2), 1.35 (d, J¼6.8, 2H, CH2), 0.89 (d, J¼6.6,
3H, CH3); 13C NMR d 163.1, 146.9, 144.5, 129.9, 109.8, 103.1, 101.2,
56.5, 29.6, 28.1, 22.3, 13.8. IR (KBr) n: 3120–2890, 1600, 1590, 1530,
1425, 1335, 1325 cmꢁ1. Anal. Calcd for C13H15NO4 (249.10): C, 62.64;
H, 6.07; N, 5.62. Found: C, 62.53; H, 6.15; N, 5.69.
Mp 107–107.5 ꢀC, GC/MS, MS m/z: 325 (Mþ, 1%), 297 (2%), 283
(27%), 239 (5%), 222 (2%), 197 (100%), 180 (5%), 167 (3%), 151 (12%),
136 (3%), 122 (3%), 108 (2%), 92 (1%), 79 (2%), 63 (2%), 50 (1%). 1H
NMR d 8.11 (s, 1H, Ar), 7.92 (s, 1H, Ar), 6.53 (s, 1H, CH), 4.43 (br s, 1H,
CH), 3.96 (s, 3H, OCH3), 2.37 (s, 3H, CH3), 2.07–2.04 (m, 1H, CH2),
1.94–1.88 (m, 1H, CH2), 1.10 (t, J¼7.4, 3H, CH3); 13C NMR d 171.8,
167.1, 152.2, 146.1, 143.7, 129.5, 114.1, 108.9, 97.6, 76.0, 56.8, 24.1,
20.4, 9.2. IR (KBr) n: 3000–2900, 1810, 1780, 1545, 1200–1180 cmꢁ1
.
Anal. Calcd for C14H15NO8 (325.08): C, 51.70; H, 4.65; N, 4.31. Found:
C, 51.40; H, 4.40; N, 4.21.
4.7.2. 2-Butyl-3,5-dihydro-9-methoxy-7-nitro-3-oxo-2H-
benzo[e][1,4]dioxepin-5-yl acetate (3c)
4.5.3. 2-Ethyl-5-hydroxy-9-methoxy-7-nitro-5H-benzo[e][1,4]-
dioxepin-3-one (4a)
GC/MS, MS m/z: 353 (Mþ, 1%), 325 (2%), 311 (14%), 281 (1%), 266
(2%), 252 (1%), 239 (5%), 197 (100%), 181 (4%), 167 (3%), 151 (8%), 136
(2%), 115 (2%), 97 (2%), 83 (1%), 69 (4%), 55 (2%).
GC/MS, MS m/z: 283 (Mþ, 27%), 239 (5%), 222 (2%), 197 (100%),
180 (5%), 167 (3%), 151 (12%),136 (3%), 122 (3%),108 (2%), 93 (1%), 79
(2%), 59 (2%). 1H NMR d 8.04 (s, 1H, Ar), 7.90 (s, 1H, Ar), 6.65 (d, J¼
5.2, 1H, CH), 4.10 (br s, 1H, CH), 3.97 (s, 3H, OCH3), 2.92 (br s, 1H,
OH), 2.06–2.03 (m, 1H, CH2), 1.92–1.88 (m, 1H, CH2), 1.11 (t, J¼7.4,
3H, CH3); 13C NMR d 171.3, 152.0, 146.0, 143.4, 129.1, 114.0, 108.8,
94.8, 78.2, 56.4, 24.0, 9.0. IR (KBr) n: 3550–3350, 3000–2850, 1810,
4.7.3. 2-Butyl-5-hydroxy-9-methoxy-7-nitro-5H-benzo[e][1,4]-
dioxepin-3-one (4c)
GC/MS, MS m/z: 311 (Mþ, 14%), 281 (1%), 266 (2%), 252 (1%), 239
(5%), 197 (100%), 181 (4%), 167 (3%), 151 (8%), 136 (2%), 122 (2%), 97
(2%), 83 (1%), 69 (4%), 55 (2%).